Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis

NCT06183203 is registered in ClinicalTrials.gov with Nebu Philip as lead sponsor.

NCT NCT06183203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06183203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis
Lead sponsor
Nebu Philip
Phase
Not applicable
Overall status
Withdrawn
Start date
February 15, 2024
Completion date
June 30, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irreversible pulpitis